439
Last Update Posted: 2018-01-18
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
72 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Drug Treatment for Alcoholics With Bipolar Disorder
The purpose of this study is to test the effectiveness of sodium valproate (Depacon) in treating individuals with alcohol dependence and comorbid bipolar disorder.
The aim of this study is to test the mood stabilizer, anticonvulsant, sodium valproate in individuals with alcohol dependence and bipolar disorder, in a double-blind, placebo-controlled, and randomized trial of 6 months duration. All subjects are treated with treatment as usual, which include lithium carbonate and individual dual recovery counseling and are randomized to either sodium valproate or placebo.
Eligibility
Relevant conditions:
Alcoholism
Bipolar Disorder
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov